Endocrine Metabolic & Immune Disorders - Drug Targets
译名:内分泌、代谢与免疫疾病-药物靶点
Endocrine Metabolic & Immune Disorders-Drug Targets
1-3
2026
影响因子区间
—
平台估算
56%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Aims & ScopeThis journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.
【译文】旨在及时回顾和发表内分泌、代谢和免疫疾病领域的实验和临床研究。特别强调对天然、合成和基因工程药物在增强或损害内分泌、代谢和免疫参数和功能方面的体液和细胞靶点的关注。此外,欢迎有关食物成分和/或营养补充剂对内分泌-代谢-免疫轴和微生物组组成的影响的课题。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |